Topic
personalized medicine
3 stories related to this topic, newest first.
sciencenews.orgscience74 days ago
Genomic and Demographic Data Enable Prediction of GLP-1 Drug Weight Loss Response
Researchers have identified that genomic and demographic data can predict the magnitude of weight loss from GLP-1 drugs. This approach involves analysis by 23andMe. The findings focus on drug response and side effects in obesity treatment.
ER
Substrate placeholder — needs reviewscience74 days ago
Researchers Identify Genetic Variants Linked to Variable Responses to Obesity Drugs
Scientists have identified genetic variants that may explain differences in individual responses to obesity medications. The findings, published in Nature, analyzed data from clinical trials involving drugs like semaglutide. This research highlights the role of genetics in person…
NA
sciencenews.orgscience74 days ago
Genetic Variations in Two Genes Linked to Weight Loss and Side Effects from GLP-1 Drugs
Research indicates that variations in two genes associated with appetite and digestion can predict greater weight loss in patients using GLP-1 drugs for obesity treatment. These genetic changes also correlate with increased risk of nausea and vomiting as side effects. The finding…
ST